In an acute sickle cell crisis, the immediate goal is to relieve pain, ensure adequate hydration, and improve oxygenation to prevent further sickling. Providing oxygen helps tissues receive enough oxygen and can reduce the polymerization of hemoglobin S that drives vaso-occlusion. Administering IV fluids lowers blood viscosity and supports perfusion, which helps tissues get blood flow and can shorten the crisis. Prompt pain control is essential because severe pain triggers stress responses and increases oxygen demand; effective analgesia usually involves IV opioids and appropriate adjuncts, allowing the patient to rest and recover. This combination targets the three most impactful factors during a vaso-occlusive crisis: pain, hydration, and oxygenation. Other measures like bed rest alone don’t treat the underlying needs of the crisis, and while infection management or preventive immunization are important in general care, they don’t address the acute signs of a crisis in the moment.

The key idea is that suspected pulmonary embolism requires immediate stabilization of breathing and rapid escalation of care. In a DVT patient with chest pain and shortness of breath, the top priority is to ensure adequate oxygenation and quickly mobilize the team for urgent assessment and treatment. Administering supplemental oxygen helps correct hypoxemia from the V/Q mismatch caused by a PE, supporting tissue oxygen delivery as the patient is watched for potential deterioration. Activating a rapid-response team brings in the necessary resources—monitors, IV access, and rapid diagnostic options like imaging—to confirm the diagnosis and implement therapy as soon as it’s safe. Chest X-ray can be helpful for ruling out other causes of chest symptoms, but it does not diagnose PE and won’t by itself treat the situation. A diuretic isn’t addressing the underlying embolic problem and could worsen hemodynamics if fluids are not appropriately managed. Starting anticoagulation is important in PE management, but it is typically considered after initial stabilization and assessment of contraindications; the immediate action focuses on ensuring oxygenation and urgent escalation so definitive therapy can be delivered promptly.

The main idea tested is that governance, security, and validation are not separate silos but are woven into every phase of the software development lifecycle in MDC3. This means each stage carries the necessary governance checks, security reviews, and validation criteria, so progress depends on meeting all three dimensions. That integrated approach ensures alignment with policies, risk controls, and evidence that the work meets security standards and acceptance criteria before moving on. So the statement is true because MDC3 builds governance alignment directly into the SDLC alongside security reviews and validation criteria, giving you traceability and consistent oversight throughout development. The other ideas—focusing only on governance, only on validation, or denying integration—don’t capture how MDC3 treats these elements as interconnected parts of the lifecycle.

Wheezing disappearing as fatigue increases signals worsening status asthmaticus because it shows air movement is dropping, not improving. In severe asthma, wheezes come from turbulent airflow through narrowed airways. As the attack worsens and the patient tires, respiratory muscles fail to sustain movement of air, so there’s less airflow overall and the chest may become quiet. That “silent chest” is a dangerous sign that the obstruction is severe and the patient may be heading toward respiratory failure, requiring urgent escalation of treatment. The other scenarios don’t indicate deterioration in the same way. A productive cough after a bronchodilator could reflect mucus production but isn’t a direct marker of worsening severity. Increased air entry throughout the chest isn’t typical in worsening asthma, where air trapping usually dampens breath sounds rather than increasing them. Stable oxygen saturation with quiet breathing suggests stability, not decline.